News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
scanx.trade Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
SIGA Technologies (SIGA) reported a profit in Q2 2026, but its stock still slipped due to contract uncertainty and declining revenue and EPS compared to the previous year. Despite a strong cash balance and no debt, the market is concerned about the volatility of …
Siga Technologies reported $38 million in Q2 product revenue, driven by TPOXX sales to the U.S. Strategic National Stockpile and international customers, resulting in a net income of $12 million. The company is in ongoing discussions for a new multiyear TPOXX procurement agreement with …
SIGA TECHNOLOGIES INC reported its Q2 2026 results with revenue of $41 million and diluted earnings per share of $0.17, both significantly down from the prior-year quarter due to shifts in product mix and lower U.S. oral TPOXX® deliveries. The company's business remains heavily …
SIGA Technologies reported a significant decline in Q2 2026 revenue and EPS due to lower TPOXX product sales and an unfavorable product mix, which compressed margins. The company delivered TPOXX to both U.S. and international customers, but the completion of a key U.S. procurement …
SIGA Technologies reported a significant drop in Q2 2026 revenue to $41.0 million, down from $81.1 million a year prior, primarily due to decreased U.S. government purchases of oral TPOXX. Net income consequently fell to $12.5 million from $35.5 million. Despite the revenue decline, …
SIGA Technologies Inc. reported $38 million in product revenues for Q2 2026, primarily from U.S. and international TPOXX deliveries, alongside a net income of $12 million and robust cash reserves. The company is advancing new U.S. contracts and international expansion efforts, despite encountering slower …
SIGA Technologies (SIGA.US) is scheduled to release its earnings report on August 6, after the market closes. This announcement informs investors and stakeholders about the upcoming financial disclosure for the company.
SIGA Technologies, Inc. (Nasdaq: SIGA) announced that its CEO Diem Nguyen and CFO Daniel Luckshire will host a webcast and conference call on Thursday, August 6, 2026, at 4:30 P.M. ET. The call will provide a business update following the release of the company's …
SIGA Technologies Inc. announced that it will host a webcast and conference call on August 6, 2026, at 4:30 P.M. ET to provide a business update following the release of its second-quarter 2026 financial results. The call will feature CEO Diem Nguyen and CFO …
This article provides a risk assessment for SIGA Technologies Inc (SIGA), detailing its volatility, financial risk, and investment risk. It notes that SIGA has a risk assessment score of 5.23, ranking 71st in the Pharmaceuticals industry, and a beta of 0.92, indicating it tends …
The article analyzes the institutional confidence score for SIGA Technologies Inc (SIGA), which stands at 5.00, placing it 72nd in the Pharmaceuticals industry. Institutional shareholding proportion increased by 10.57% quarter-over-quarter, with HOTCHKIS & WILEY as the largest institutional shareholder despite a slight decrease in …
This article provides an in-depth analysis of SIGA Technologies Inc. (SIGA) stock, including real-time quotes, market trends, key financials, and trading strategies. It highlights the company's strong fundamentals and growth potential, despite recent stock market performance, and details its flagship product, TPOXX, an antiviral …
This article provides a valuation analysis of SIGA Technologies Inc (SIGA), highlighting its current valuation score and financial ratios. The company's valuation score is 5.26, ranking low within the Pharmaceuticals industry. It also details SIGA's current P/E ratio, noting its position relative to recent …
This article provides a detailed financial overview of SIGA Technologies Inc. It presents the company's financial summary, including income statement, balance sheet, and cash flow statement data, both quarterly and annually. Key financial indicators like EPS, revenue, net profit, net margin, and gross margin …
This article provides a detailed cash flow statement for SIGA Technologies Inc (SIGA), outlining quarterly and annual data for operating, investing, and financing activities. It presents financial figures such as operating cash flow, net income from continuing operations, capital expenditures, and free cash flow. …
This article provides a revenue breakdown for SIGA Technologies Inc (SIGA), focusing on its regional revenue contributions. As of the latest update, relevant data for future fiscal years and business segments has not yet been disclosed by the company. The current disclosed regional revenue …
This article details the shareholder structure of SIGA Technologies Inc (SIGA), listing its major individual and institutional holders, and categorizing shareholders by type. It also provides a historical overview of institutional shareholding data and recent shareholder activity, along with ETFs that hold SIGA shares. …
This article provides a comprehensive stock analysis of SIGA Technologies Inc (SIGA) based on TradingKey's stock score, highlighting its relatively healthy fundamentals and high growth potential, despite a recent weak stock market performance. The company's valuation is considered fairly valued in the Pharmaceuticals industry, …
SIGA Technologies reported significant financial growth in Q2 2025, with revenues reaching $81.1 million and net income increasing to $35.5 million due to strong government sales of TPOXX. The company secured additional BARDA funding and paid a special cash dividend. However, future international sales …
Search by ticker symbol or company name and select a result to open its chart.